Compare Abbott India with Torrent Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ABBOTT INDIA vs TORRENT PHARMA - Comparison Results

ABBOTT INDIA     Change

Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmace... More

TORRENT PHARMA 
   Change

Torrent Pharmaceuticals Ltd. is the flagship company of the Torrent Group set up in 1959. Based in Ahmedabad, it was promoted by Mr U.N. Mehta initially as Trinity Laboratories Ltd. and was later renamed to its current name. The company derives its r... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ABBOTT INDIA TORRENT PHARMA ABBOTT INDIA/
TORRENT PHARMA
 
P/E (TTM) x 46.7 38.1 122.5% View Chart
P/BV x 15.2 9.6 158.2% View Chart
Dividend Yield % 0.5 0.6 71.4%  

Financials

 ABBOTT INDIA   TORRENT PHARMA
EQUITY SHARE DATA
    ABBOTT INDIA
Mar-19
TORRENT PHARMA
Mar-19
ABBOTT INDIA/
TORRENT PHARMA
5-Yr Chart
Click to enlarge
High Rs8,8341,964 449.8%   
Low Rs5,4581,245 438.4%   
Sales per share (Unadj.) Rs1,731.1453.4 381.8%  
Earnings per share (Unadj.) Rs211.925.8 821.9%  
Cash flow per share (Unadj.) Rs219.962.3 353.0%  
Dividends per share (Unadj.) Rs65.0017.00 382.4%  
Dividend yield (eoy) %0.91.1 85.9%  
Book value per share (Unadj.) Rs945.2279.2 338.6%  
Shares outstanding (eoy) m21.25169.22 12.6%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.13.5 116.7%   
Avg P/E ratio x33.762.2 54.2%  
P/CF ratio (eoy) x32.525.8 126.2%  
Price / Book Value ratio x7.65.7 131.5%  
Dividend payout %30.765.9 46.5%   
Avg Mkt Cap Rs m151,848271,513 55.9%   
No. of employees `0003.513.6 25.6%   
Total wages/salary Rs m4,35614,038 31.0%   
Avg. sales/employee Rs Th10,555.55,642.6 187.1%   
Avg. wages/employee Rs Th1,249.91,032.4 121.1%   
Avg. net profit/employee Rs Th1,292.2320.9 402.7%   
INCOME DATA
Net Sales Rs m36,78676,728 47.9%  
Other income Rs m1,133571 198.6%   
Total revenues Rs m37,91977,299 49.1%   
Gross profit Rs m6,04719,831 30.5%  
Depreciation Rs m1696,177 2.7%   
Interest Rs m235,038 0.4%   
Profit before tax Rs m6,9899,187 76.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-3,570 0.0%   
Tax Rs m2,4851,254 198.3%   
Profit after tax Rs m4,5034,363 103.2%  
Gross profit margin %16.425.8 63.6%  
Effective tax rate %35.613.6 260.6%   
Net profit margin %12.25.7 215.3%  
BALANCE SHEET DATA
Current assets Rs m27,61050,375 54.8%   
Current liabilities Rs m8,56951,653 16.6%   
Net working cap to sales %51.8-1.7 -3,108.1%  
Current ratio x3.21.0 330.4%  
Inventory Days Days6092 65.4%  
Debtors Days Days2768 40.1%  
Net fixed assets Rs m1,05783,648 1.3%   
Share capital Rs m213846 25.1%   
"Free" reserves Rs m19,87346,397 42.8%   
Net worth Rs m20,08647,244 42.5%   
Long term debt Rs m039,129 0.0%   
Total assets Rs m29,409141,209 20.8%  
Interest coverage x311.62.8 11,035.3%   
Debt to equity ratio x00.8 0.0%  
Sales to assets ratio x1.30.5 230.2%   
Return on assets %15.46.7 231.2%  
Return on equity %22.49.2 242.8%  
Return on capital %34.912.3 283.0%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m36922,103 1.7%   
Fx outflow Rs m4,9185,522 89.1%   
Net fx Rs m-4,54916,581 -27.4%   
CASH FLOW
From Operations Rs m4,99117,981 27.8%  
From Investments Rs m-2,570-2,413 106.5%  
From Financial Activity Rs m-1,428-13,145 10.9%  
Net Cashflow Rs m9932,380 41.7%  

Share Holding

Indian Promoters % 0.0 71.5 -  
Foreign collaborators % 75.0 0.0 -  
Indian inst/Mut Fund % 7.9 7.0 112.5%  
FIIs % 0.1 12.6 0.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 17.1 8.8 194.3%  
Shareholders   18,270 26,511 68.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ABBOTT INDIA With:   FULFORD INDIA  VENUS REMEDIES  CIPLA  WOCKHARDT  AUROBINDO PHARMA  

Compare ABBOTT INDIA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Plunges 746 Points; Banking & Metal Stocks Bleed(Closing)

Indian share markets witnessed huge selling pressure today and extended losses as the session progressed, dragged down by heavy selling in metal and banking stocks.

Related Views on News

TORRENT PHARMA Announces Quarterly Results (2QFY21); Net Profit Up 27.0% (Quarterly Result Update)

Oct 27, 2020 | Updated on Oct 27, 2020

For the quarter ended September 2020, TORRENT PHARMA has posted a net profit of Rs 3 bn (up 27.0% YoY). Sales on the other hand came in at Rs 20 bn (up 0.6% YoY). Read on for a complete analysis of TORRENT PHARMA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (1QFY21); Net Profit Up 54.2% (Quarterly Result Update)

Aug 18, 2020 | Updated on Aug 18, 2020

For the quarter ended June 2020, ABBOTT INDIA has posted a net profit of Rs 2 bn (up 54.2% YoY). Sales on the other hand came in at Rs 11 bn (up 6.5% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

TORRENT PHARMA Announces Quarterly Results (1QFY21); Net Profit Up 48.6% (Quarterly Result Update)

Jul 31, 2020 | Updated on Jul 31, 2020

For the quarter ended June 2020, TORRENT PHARMA has posted a net profit of Rs 3 bn (up 48.6% YoY). Sales on the other hand came in at Rs 21 bn (up 1.7% YoY). Read on for a complete analysis of TORRENT PHARMA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (4QFY20); Net Profit Down 2.0% (Quarterly Result Update)

Jun 9, 2020 | Updated on Jun 9, 2020

For the quarter ended March 2020, ABBOTT INDIA has posted a net profit of Rs 1 bn (down 2.0% YoY). Sales on the other hand came in at Rs 10 bn (up 6.1% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (3QFY20); Net Profit Up 59.5% (Quarterly Result Update)

Feb 11, 2020 | Updated on Feb 11, 2020

For the quarter ended December 2019, ABBOTT INDIA has posted a net profit of Rs 2 bn (up 59.5% YoY). Sales on the other hand came in at Rs 11 bn (up 13.8% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

More Views on News

Most Popular

Why Gold Hit Lower Circuit(Fast Profits Daily)

Jan 11, 2021

Were you shocked that bullion prices hit lower circuits on Friday on the MCX? Find out why it happened...

Time to Book Profits in Pharma Stocks(Fast Profits Daily)

Jan 15, 2021

In this video, I'll show you why it might be the right time to take money of the table in pharma stocks.

A Rare Chance to Invest in Potential Multibaggers in 2021(Profit Hunter)

Jan 11, 2021

Our ace stock picker is ready to capitalise on a big growth opportunity.

Smallcap Stocks: Your Best Bet for 2021 and Beyond(Profit Hunter)

Jan 15, 2021

The pandemic failed to thwart Richa's investing success formula for 2020.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

ABBOTT INDIA SHARE PRICE


Jan 22, 2021 (Close)

TRACK ABBOTT INDIA

  • Track your investment in ABBOTT INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ABBOTT INDIA - FRESENIUS KABI ONCO. COMPARISON

COMPARE ABBOTT INDIA WITH

MARKET STATS